High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$8.9M
$8,910,429
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $2,762,822Largex11 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$1,031,770Largex11
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $1,031,770Largex11 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary Sell
|
2026-03-03 | $409,851 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-02 | $93,632x6 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-02-02 | $91,490x5 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Discretionary Sell
|
2025-12-12 | $339,711 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-12-01 | $91,457x7 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Gray Nancy Ryan
• Director
Discretionary SellΔOwn -27.1%
2025-11-07
$1,350,012Largex2
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary SellΔOwn -27.1%
|
2025-11-07 | $1,350,012Largex2 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
LAMATTINA JOHN L
• Director
Discretionary Sell
2025-11-07
$858,576x2
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary Sell
|
2025-11-07 | $858,576x2 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-11-03 | $89,219x4 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-10-01 | $83,800x4 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Aryeh Jason
• Director
Discretionary Sell
2025-09-23
$1,708,088Largex3
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary Sell
|
2025-09-23 | $1,708,088Largex3 | S | Form 4 |